These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9796544)

  • 1. Down detection.
    Ezzell C
    Sci Am; 1998 Nov; 279(5):28-9. PubMed ID: 9796544
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal serum screening for Down syndrome before 15 weeks.
    Cuckle H; Lilford R; Jones R
    Am J Obstet Gynecol; 1994 Mar; 170(3):959. PubMed ID: 7511335
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum screening in a Japanese population.
    Sehmi IK; Jones RG; Gordon Y; Cuckle HS
    Prenat Diagn; 2000 May; 20(5):437-9. PubMed ID: 10820418
    [No Abstract]   [Full Text] [Related]  

  • 4. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contingent triple-screening for Down syndrome in the second trimester is not a cost-effective prenatal screening strategy in Mainland Chinese population.
    Li DZ
    Prenat Diagn; 2010 May; 30(5):493. PubMed ID: 20440741
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV; Rozenberg P; Bernard JP; Ville Y
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
    [No Abstract]   [Full Text] [Related]  

  • 7. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
    Bahado-Singh R; Shahabi S; Karaca M; Mahoney MJ; Cole L; Oz UA
    Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of serum markers in antenatal screening for Down's syndrome.
    Wald NJ; Watt HC
    J Med Screen; 1994 Apr; 1(2):117-20. PubMed ID: 8790499
    [No Abstract]   [Full Text] [Related]  

  • 9. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential first and second trimester screening tests: correlation of the markers' levels in normal versus Down syndrome affected pregnancies.
    Maymon R; Bergman M; Segal S; Dreazen E; Weinraub Z; Herman A
    Prenat Diagn; 2001 Dec; 21(13):1175-7. PubMed ID: 11787048
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective prenatal serum screening for Down syndrome in Venezuela.
    Alvarez-Nava F; Soto M; Morales-Machín A; Rojas A; Urdaneta K; Cañizález J
    Int J Gynaecol Obstet; 2008 Dec; 103(3):241-5. PubMed ID: 18817910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial experiences with the triple test in Austria].
    Obwegeser R; Deutinger J; Bieglmayer C; Bernaschek G
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():243. PubMed ID: 7509675
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
    Wenstrom KD; Owen J; Chu Dc; Boots L
    Am J Obstet Gynecol; 1999 Oct; 181(4):887-92. PubMed ID: 10521748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal detection of Down syndrome.
    Smith CV
    Nebr Med J; 1995 Aug; 80(8):268-70. PubMed ID: 7566251
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
    Wenstrom KD; Owen J; Chu DC; Boots L
    Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Triple screening for trisomy 21: prospective results of 7039 assessments].
    Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
    Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of Down syndrome screening by maternal serum detection in mid-pregnancy].
    Liu YH; Li LF; Wu YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):532-4, 537. PubMed ID: 20335129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual analyte screening for fetal Down syndrome in pregnant women over 35 years of age.
    Cavalli P; Gnocchi E; Pennacchio A; Morrica B
    Prenat Diagn; 1998 Jun; 18(6):637-8. PubMed ID: 9664616
    [No Abstract]   [Full Text] [Related]  

  • 20. Down syndrome screening in the first and second trimesters: what do the data show?
    Rosen T; D'Alton ME
    Semin Perinatol; 2005 Dec; 29(6):367-75. PubMed ID: 16533649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.